Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-022-03160-1
Abstract: The safety and anti-tumor activity of penpulimab in patients with advanced upper gastrointestinal (UGI) cancers were evaluated in this study. Patients with advanced UGI cancers naive to immune checkpoint inhibitors were enrolled in two trials… read more here.
Keywords: safety; ugi cancers; phase trial; trial ... See more keywords
PTH-016 How often do we miss upper gastrointestinal tumours at gastroscopy?
Sign Up to like & getrecommendations! Published in 2017 at "Gut"
DOI: 10.1136/gutjnl-2017-314472.413
Abstract: Introduction Upper gastrointestinal (UGI) cancers are an important cause of morbidity and mortality across the western world and are often detected late. Whilst for colonoscopy the post procedure cancer rate is set at read more here.
Keywords: miss rate; upper gastrointestinal; pth 016; ugi cancers ... See more keywords